Lawrence Otto Klein, CBO & COO at CRISPR Therapeutics AG (CRSP), sold 188,000 shares at $128.20 ($24.1M) on 2021-03-23, disclosed to the SEC on 2021-03-25.
Open-market sale of $24.1M CRSP by CBO & COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $126.97 | 12,000 | $1.5M | 6.3% |
| 2 | $128.20 | 88,000 | $11.3M | 46.8% |
| 3 | $128.20 | 88,000 | $11.3M | 46.8% |
| Total | $128.12 avg | 188,000 | $24.1M | 100% |
| Filing → |
| ORKA | SELL | 2026-09-01 | $6.9M | — | Filing → |
| ORKA | SELL | 2026-06-15 | $120K | — | Filing → |
| ORKA | SELL | 2026-03-17 | $71K | — | Filing → |